Kim Walpole

So, you know, this process is a little longer.

And when we're talking with investors, they're actually looking at our sales pipeline.

We actually have two trials that are completed.

We're working with four customers.

We've got five studies total.

And like I said, we've got seven coming up.

We're rolling one out right now.

Absolutely.

Yeah.

Yeah.

Over the last two months, you know, we've closed about 250,000 in new bookings.

We are at eight full-time and then we've got four part-time and a couple of interns.

San Diego.

We've got a couple out in San Francisco as well.

No, actually right now, you know, this is kind of a very sticky technology because when we're talking about clinical trials, like I said, you've got a treatment to market that's going to take anywhere from nine to 15 years.

And so what we're finding is, you know, we've got one customer that came to us.

They ran their first trial.

They liked it so much.

We saved them three hours on admin tasks per day per person.

and then decrease their data errors by 20%.